Key facts
- OSSIO’s last known valuation is $141.7M.
- It has raised $102.1M; the latest was Later Stage VC ($27.6M) in Dec 2024.
- Notable investors include OurCrowd, Arc Ventures (United States), Courage Capital Management, MVM Partners, OCV Partners — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for OSSIO
- ·The full record, as it builds
Funding rounds
No funding rounds for OSSIO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OSSIO
Operator of an orthopedic fixation company intended to provide the first credible replacement for metal implants. The company's fixation devices utilize intelligent bone regeneration technology and are based on a biocomposite material platform and also offer reinforcing mineral fibers made of a mineral blend, enabling patients to regenerate tissues and bones and recover from orthopedic disorders.
- Sector
- Healthcare
- HQ
- Woburn, MA, United States
- Founded
- 2014
- Employees
- 137
- Website
- ossio.io/
- Ownership
- Privately Held (backing)
OSSIO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OSSIO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OSSIO in its N-PORT filings yet. We sweep new filings monthly.